Elicio Therapeutics
Price & Volume
Stats
See more52W Range | $2.66-$16 |
Market Cap | $79.5M |
Shares Short | 1M |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$2.31 |
News
See moreYahoo Finance • last month
Elicio Therapeutics drops 5%, prices $15M direct offering
Yahoo Finance • last month
Elicio Therapeutics Announces Pricing of $15 Million Registered Direct Offering
Yahoo Finance • last month
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Elicio Therapeutics, Inc. - ELTX
Yahoo Finance • 2 months ago
Top Biotech Gainers: QURE Rallies On AMT-130 Update, LNAI On Track, FTH Eyes Q4 Data, ELTX On Watch
About
CEO | Mr. Robert T. Connelly |
Address | 451 D Street, Boston, MA, United States, 02210 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 33 |